References
- 1DoguOSevimSCamdevirenHet alPrevalence of essential tremor: door-to-door neurologic exams in Mersin Province, TurkeyNeurology2003611804180614694055
- 2LouisEDOttmanRHauserWAHow common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the worldMov Disord19981351010.1002/mds.8701301059452318
- 3Benito-LeonJLouisEDEssential tremor: emerging views of a common disorderNat Clin Pract Neurol20062666678quiz 2p following 69110.1038/ncpneuro034717117170
- 4LouisEDBenito-LeonJBermejo-ParejaFSelf-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based studyEur J Neurol2007141138114617708753
- 5LouisEDFaustPLVonsattelJPet alNeuropathological changes in essential tremor: 33 cases compared with 21 controlsBrain2007130329730710.1093/brain/awm26618025031
- 6AxelradJELouisEDHonigLSet alReduced Purkinje cell number in essential tremor: a postmortem studyArch Neurol20086510110710.1001/archneurol.2007.818195146
- 7LouisEDFaustPLVonsattelJPPurkinje cell loss is a characteristic of essential tremorParkinsonism Relat D20111740640910.1016/j.parkreldis.2011.05.004
- 8LouisEDVonsattelJPThe emerging neuropathology of essential tremorMov Disord20082317418210.1002/mds.2173117999421
- 9LouisEDVonsattelJPHonigLSet alEssential tremor associated with pathologic changes in the cerebellumArch Neurol2006631189119310.1001/archneur.63.8.118916908751
- 10ShatunovASambuughinNJankovicJet alGenomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23Brain20061292318233110.1093/brain/awl12016702189
- 11IllarioshkinSNRakhmonovRAIvanova-SmolenskaiaIAet al[Molecular genetic analysis of essential tremor]Genetika2002381704170912575458
- 12StefanssonHSteinbergSPeturssonHet alVariant in the sequence of the LINGO1 gene confers risk of essential tremorNat Genet20094127727910.1038/ng.29919182806
- 13Vilarino-GuellCRossOAWiderCet alLINGO1 rs9652490 is associated with essential tremor and Parkinson diseaseParkinsonism Relat D20101610911110.1016/j.parkreldis.2009.08.006
- 14ThierSLorenzDNothnagelMet alLINGO1 polymorphisms are associated with essential tremor in EuropeansMov Disord201025709715
- 15Vilarino-GuellCWiderCRossOAet alLINGO1 and LINGO2 variants are associated with essential tremor and Parkinson diseaseNeurogenetics20101140140810.1007/s10048-010-0241-x20369371
- 16ClarkLNParkNKisselevSet alReplication of the LINGO1 gene association with essential tremor in a North American populationEur J Hum Genet20101883884320372186
- 17TanEKTeoYYPrakashKMet alLingo1 variant increases risk of familial essential tremorNeurology2009731161116210.1212/WNL.0b013e3181bacfc919805735
- 18ZuoXJiangHGuoJFet alScreening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson's disease in Chinese populationNeurosci Lett2010481697210.1016/j.neulet.2010.06.04120600614
- 19WuYWRongTYLiHHet alAnalysis of Lingo1 variant in sporadic and familial essential tremor among AsiansActa Neurol Scand201112426426821158743
- 20Lorenzo-BetancorOGarcia-MartinECervantesSet alLack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremorEur J Neurol2011181085108921219542
- 21BourassaCVRiviereJBDionPAet alLINGO1 Variants in the French-Canadian PopulationPlos One20116e1625421264305
- 22LouisEDEnvironmental Epidemiology of Essential TremorNeuroepidemiology20083113914910.1159/00015152318716411
- 23Carim-ToddLEscarcellerMEstivillXSumoyLLRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortexEur J Neurosci2003183167318214686891
- 24ChenYAuliaSLiLTangBLAMIGO and friends: an emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifsBrain Res Rev20065126527410.1016/j.brainresrev.2005.11.00516414120
- 25MosyakLWoodADwyerBet alThe structure of the Lingo-1 ectodomain, a module implicated in central nervous system repair inhibitionJ Biol Chem2006281363783639010.1074/jbc.M60731420017005555
- 26LaurenJAiraksinenMSSaarmaMTimmuskTA novel gene family encoding leucine-rich repeat transmembrane proteins differentially expressed in the nervous systemGenomics20038141142110.1016/S0888-7543(03)00030-212676565
- 27HommaSShimadaTHikakeTYaginumaHExpression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryoGene Expr Patterns2009912610.1016/j.gep.2008.09.00418848646
- 28HainesBPRigbyPWExpression of the Lingo/LERN gene family during mouse embryogenesisGene Expr Patterns20088798610.1016/j.modgep.2007.10.00318297755
- 29LlorensFGilVIraolaSet alDevelopmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1lDev Neurobiol20086852154110.1002/dneu.2060718186492
- 30MiSLeeXShaoZet alLINGO-1 is a component of the Nogo-66 receptor/p75 signaling complexNat Neurosci2004722122810.1038/nn118814966521
- 31ZhangZXuXZhangYet alLINGO-1 interacts with WNK1 to regulate nogo-induced inhibition of neurite extensionJ Biol Chem2009284157171572810.1074/jbc.M80875120019363035
- 32InoueHLinLLeeXet alInhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease modelsProc Natl Acad Sci U S A2007104144301443510.1073/pnas.070090110417726113
- 33
- 34TrifunovskiAJosephsonARingmanAet alNeuronal activity-induced regulation of Lingo-1Neuroreport2004152397240010.1097/00001756-200410250-0001915640763
- 35ShaoZBrowningJLLeeXet alTAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regenerationNeuron20054535335910.1016/j.neuron.2004.12.05015694322
- 36WangKCKimJASivasankaranRet alP75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgpNature2002420747810.1038/nature0117612422217
- 37YamashitaTTohyamaMThe p75 receptor acts as a displacement factor that releases Rho from Rho-GDINat Neurosci2003646146712692556
- 38McGeeAWStrittmatterSMThe Nogo-66 receptor: focusing myelin inhibition of axon regenerationTrends Neurosci200326193810.1016/S0166-2236(03)00062-612689770
- 39HuntDCoffinRSAndersonPNThe Nogo receptor, its ligands and axonal regeneration in the spinal cord; a reviewJ Neurocytol2002319312010.1023/A:102394142178112815233
- 40MiSMillerRHLeeXet alLINGO-1 negatively regulates myelination by oligodendrocytesNat Neurosci2005874575110.1038/nn146015895088
- 41LeeZYangZShaoXet alNGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelinationJ Neurosci20072722022510.1523/JNEUROSCI.4175-06.200717202489
- 42MiSHuBHahmKet alLINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitisNat Med2007131228123310.1038/nm166417906634
- 43ZhaoXHJinWLWuJet alInactivation of glycogen synthase kinase-3beta and up-regulation of LINGO-1 are involved in LINGO-1 antagonist regulated survival of cerebellar granular neuronsCell Mol Neurobiol20082872773510.1007/s10571-007-9258-618183482
- 44JeonCYKimHJMoriiHet alNeurite outgrowth from PC12 cells by basic fibroblast growth factor (bFGF) is mediated by RhoA inactivation through p190RhoGAP and ARAP3J Cell Physiol2247869410.1002/jcp.2218420578246
- 45HakariyaTShidaYSakaiHet alEGFR signaling pathway negatively regulates PSA expression and secretion via the PI3K-Akt pathway in LNCaP prostate cancer cellsBiochem Biophys Res Commun20063429210010.1016/j.bbrc.2006.01.10616472761
- 46FreudlspergerCBurnettJRFriedmanJAet alEGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapyExpert Opin Ther Targets15637410.1517/14728222.2011.54144021110697
- 47Ayuso-SacidoAMoliternoJABoockvarJAActivated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in neural stem cellsNeuro-Oncology200911682682
- 48Ayuso-SacidoAMoliternoJAKratovacSet alActivated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cellsJ Neuro-Oncol20109732333710.1007/s11060-009-0035-x
- 49SakanakaMPengHWenTCet alEpidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuriesJ Cerebr Blood F Met199818349360
- 50Chen-PlotkinAHuWSiderowfAet alPlasma EGF Levels Predict Cognitive Decline in Parkinson's DiseaseNeurology201176A176A176
- 51WongRWCGuillaudLThe role of epidermal growth factor and its receptors in mammalian CNSCytokine Growth F R20041514715610.1016/j.cytogfr.2004.01.004
- 52KempermannGSteinerBWolfSAAdult neurogenesis and neurodegenerative diseaseRegen Med20061152810.2217/17460751.1.1.1517465817
- 53FuQLHuBWuWet alBlocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transectionInvest Ophthalmol Vis Sci20084997598510.1167/iovs.07-119918326721
- 54MiSSandrockAMillerRHLINGO-1 and its role in CNS repairInt J Biochem Cell Biol2008401971197810.1016/j.biocel.2008.03.01818468478
- 55TataruLCBogdaniciCM[Glaucoma–neurodegenerative disease]Rev Med Chir Soc Med Nat Iasi20091131120112520191885
- 56GuptaNYucelYHGlaucoma as a neurodegenerative diseaseCurr Opin Ophthalmol20071811011410.1097/ICU.0b013e3280895aea17301611
- 57JiBSandrockAMillerRHet alLINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injuryMol Cell Neurosci20063331132010.1016/j.mcn.2006.08.00317011208
- 58RudickRAMiSSandrockAW
Jr LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidenceExpert Opin Biol Ther200881561157010.1517/14712598.8.10.156118774923 - 59WilkinsAMajedHLayfieldRet alOligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factorJ Neurosci2003234967497412832519
- 60CaoQHeQWangYet alTransplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injuryJ Neurosci302989300110.1523/JNEUROSCI.3174-09.201020181596
- 61JakovcevskiIFilipovicRMoZet alOligodendrocyte development and the onset of myelination in the human fetal brainFront Neuroanat20093510.3389/neuro.05.005.200919521542
- 62BaerASSyedYAKangSUet alMyelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signallingBrain200913246548110.1093/brain/awn33419208690
- 63RajasekharanSBakerKAHornKEet alNetrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoADevelopment200913641542610.1242/dev.01823419141671
- 64Vilarino-GuellCRossOAWiderCet alLINGO1 rs9652490 is associated with essential tremor and Parkinson diseaseParkinsonism Relat D1610911110.1016/j.parkreldis.2009.08.006
- 65DengHGuSJankovicJLINGO1 variants in essential tremor and Parkinson's diseaseActa Neurol Scand20111251710.1111/j.1600-0404.2011.01516.x.201121470193
- 66WangGJYangPXieHGGene variants in noncoding regions and their possible consequencesPharmacogenomics2006720320910.2217/14622416.7.2.20316515399
- 67KelsoeJRGreenwoodTASchorkNJEskinEIdentification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samplesMol Psychiatr20061112513310.1038/sj.mp.4001764
- 68KelsoeJRGreenwoodTAPromoter and intronic variants affect the transcriptional regulation of the human dopamine transporter geneGenomics20038251152010.1016/S0888-7543(03)00142-314559208
- 69HoffstedtJWahlenKSjolinEThe common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysisJ Lipid Res20084960761110.1194/jlr.M700448-JLR20018048838
- 70RouleauGAXiongLCatoireHet alMEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levelsHum Mol Genet2009181065107410.1093/hmg/ddn44319126776
- 71NgCETangBLNogos and the Nogo-66 receptor: factors inhibiting CNS neuron regenerationJ Neurosci Res20026755956510.1002/jnr.1013411891768
- 72FunahashiSHasegawaTNaganoASatoKDifferential expression patterns of messenger RNAs encoding Nogo receptors and their ligands in the rat central nervous systemJ Comp Neurol200850614116010.1002/cne.2154117990276